english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

New special section: "Mediator° - the criminal trial"

  The 2019 "Prescrire Prize" is awarded in Paris to
  3 noteworthy books about health and healthcare

Axicabtagene ciloleucel (Yescarta°) in certain types of lymphoma when other treatment options have been exhausted

In the October issue of Prescrire International: clear shortcomings in the independence of French medical schools

"Faces of Mediator", a new book published by Prescrire

Paracetamol: patients need to be more aware of the harms

Secondary cardiovascular prevention: dubious benefits of evolocumab (Repatha°) and alirocumab (Praluent°)

Trials funded by drug companies: publication or publicity?

Erenumab (Aimovig°) for the prevention of migraine attacks: decrease in the frequency of attacks in some patients, but uncertainty over cardiovascular effects

In the September edition of Prescrire International: sartan medicines contaminated by impurities which are probable carcinogens

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90